CARLSBAD, Calif., March 1, 2022 /PRNewswire/ -- Ionis
Pharmaceuticals, Inc. (Nasdaq: IONS) today announced that
management will participate in a panel discussion on orphan
neurological disease therapeutics at the virtual Cowen
42nd Annual Health Care Conference at 9:10 a.m. ET on Monday, March 7, 2022.
A live webcast of this presentation can be accessed on the
Investors & Media section of the Ionis website at
www.ionispharma.com. A replay will be available for a limited
time.
About Ionis Pharmaceuticals
For more than 30 years, Ionis has been the leader in RNA-targeted
therapy, pioneering new markets and changing standards of care with
its novel antisense technology. Ionis currently has three marketed
medicines and a premier late-stage pipeline highlighted by
industry-leading neurological and cardiometabolic franchises. Our
scientific innovation began and continues with the knowledge that
sick people depend on us, which fuels our vision of becoming a
leading, fully-integrated biotechnology company.
To learn more about Ionis visit www.ionispharma.com and
follow us on twitter @ionispharma.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ionis-to-present-at-the-cowen-annual-health-care-conference-301492185.html
SOURCE Ionis Pharmaceuticals, Inc.